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Complex IMany cancer cells are characterized by high rate of glycolysis and reduced rate of aerobic respiration, whose
mechanism is still elusive. Here we investigate the down-regulation of oxidative phosphorylation (OXPHOS)
in K-ras transformed mouse ﬁbroblasts as compared to a control counterpart. Transcriptional analysis
showed different expression levels of several OXPHOS nuclear genes in the two cell lines. In particular,
during the exponential growth phase most genes encoding proteins of Complex I were expressed at lower
levels in transformed cells. Consistently, a signiﬁcant decrease of Complex I content was found in
transformed cells. Moreover, analysis of NAD-dependent respiration and ATP synthesis indicated a strong
decrease of Complex I activity in the mitochondria from neoplastic cells, that was conﬁrmed by direct assay
of the enzyme redox activity. At variance, succinate-dependent respiration and ATP synthesis were not
signiﬁcantly affected. Taken together, our results provide the new insight that the reduction of respiration
observed in K-ras transformed cells is speciﬁcally due to a Complex I activity decrease.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Many tumours [1,2] are characterized by a high rate of glycolysis
with production of lactate even in the presence of oxygen, and by a
reduced rate of aerobic respiration, the so-called Warburg effect [3].
Thismetabolic switchmay be of advantage for tumor cells because the
rate of ATP production is higher even if its efﬁciency is considerably
lower [4]; in addition blockade of the complete oxidation of pyruvate
saves precursors for biosynthetic pathways that are required for rapid
growth of the tumour [5] and induces accumulation of metabolites
that activate genes important for tumour progression [6]. The
enhanced glycolysis accompanied by decreased OXPHOS is not the
case for all tumours [1,7] and several excised tumours use more
OXPHOS than glycolysis [2].on; HIF-1, hypoxia-inducible
TMRM, tetramethylrhodamine
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ll rights reserved.Several explanations have been proposed as molecular basis of
the Warburg effect. Cancers may be prevailingly glycolytic because
they are hypoxic [2]. Hypoxia due to rapid tumour growth
stimulates the expression of the transcriptional factor HIF-1α
(hypoxia-inducible factor-1α subunit) that induces transcription of
glycolytic enzymes [8]; the concomitant decrease of mitochondrial
respiration has been thought to be a direct consequence of the HIF-
1α increase, since the enhanced expression of pyruvate dehydro-
genase kinase inhibits pyruvate dehydrogenase and decreases
carbon input into the Krebs cycle [9]. At the same time, however,
HIF-1 causes a switch in the nuclear-encoded subunit 4 of
cytochrome oxidase from the isoform COX4-1 to COX4-2 resulting
in more efﬁcient electron delivery to oxygen [10,11]. Nevertheless, a
decrease of the respiratory chain activity has been observed in
several tumours [12]. This latter observation has brought to
postulate an opposite sequence of events, with reduction of
respiration preceding a compensatory increase of glycolysis. In
favour of the second interpretation there is the observation of a
mitochondrial dysfunction due to transcriptional deregulation of
several mitochondrial proteins [13,14]. In this scenario, p53
mutations, frequently observed in cancer, have been proposed to
represent the primary cause of respiration decrease by preventing
the correct assembly of cytochrome oxidase [15]. Recent studies
indicate that mitochondrial dysfunction is one of the more recurrent
features of cancer cells [16,12], as reported at microscopic,
molecular, biochemical, and genetic level [17-19]. Mitochondrial
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been involved in the generation of mitochondrial abnormalities
[18,20].
Although cancer cells under several conditions, including
hypoxia, oncogene activation, mDNA mutation [21-23], may sub-
stantially differ in their ability to use oxygen, only few reports have
been able to identify a strict association between metabolic changes
in cancer cells and mitochondrial complexes composition and
activity. For example, in renal oncocytomas [24] the NADH
dehydrogenase activity and protein content of Complex I were
found to be strongly depressed; subsequently, in a thyroid
oncocytoma cell line [25] a similar decrease of Complex I activity
was ascribed to a speciﬁc mutation in the ND1 gene of mitochon-
drial DNA. In some hereditary tumours (renal cell carcinomas) a
correlation has been identiﬁed between mitochondrial dysfunctions
and content of OXPHOS complexes [26]. For example, the low
content of Complex V, often observed in clear cell type renal cell
carcinomas and in chromophilic tumours, seems to indicate that the
mitochondria were in an inefﬁcient structural and functional state
[26]. However, it cannot be excluded that, in some cases, the
structural alteration of Complex V may offer a functional advantage
to cells exhibiting a deﬁcient respiratory chain [27]. Moreover,
recent experimental evidence has shed some light on a pivotal role
of mitochondrial morphology in the control of important mitochon-
drial functions such as apoptosis [28] and oxidative phosphorylation
[29]. In particular, dysregulated mitochondrial fusion and ﬁssion
events can now be regarded as playing an important role in cancer
onset and maintaining [30]. At present, however, a reliable
understanding is still lacking of the role, if any, that mitochondria
play in neoplastic transformation.
In order to critically analyze the molecular basis of the change of
carbon metabolism in cancer cells, in this study we compare two cell
lines that have been previously characterized [13,14, 31,32], that is
NIH3T3 mouse ﬁbroblasts (that we refer to as control, or C) and
NIH3T3 cells transformed by an activated form of the K-ras oncogene
[32,33] (that we refer to as transformed, or T). Ras proteins are
intracellular switches whose activation state (i.e. their binding to GDP
or GTP) controls downstream pathways leading to cell growth and
differentiation. The activation state of Ras proteins is governed
through the competing action of GTPase Activating Proteins (GAP)
and Guanine nucleotide Exchange Factors (GEF). Mutation of the ras
gene is a critical event in the onset of different malignant phenotypes
[34]. Also deregulation of either GAP or GEF activity may result in
hypo-or hyper-activation of downstream pathway(s), so that for
instance over-expression of a GEF or inactivation of a GAP may both
result in cell transformation [35,36].
Cells harbouring k-ras mutations were consistently found to have
an increased expression of the glucose transporter GLUT1 and an
enhanced glycolytic rate, presumably as a compensation to glucose
deprivation [37]. In this study we show that the major phenotypic
change of T ﬁbroblasts is a dramatic loss of activity and content of
respiratory Complex I (NADH-CoQ oxidoreductase), resulting in a
strong decrease of both NAD-linked respiration and ATP synthesis
rate. Accordingly, a signiﬁcant change in the expression of several
genes encoding subunits of the mitochondrial oxidative phosphory-
lation complexes, and in particular of Complex I, was observed in T
cells.
2. Materials and methods
2.1. Cell culture
Control mouse ﬁbroblasts (obtained from the ATCC, Manassas, VA,
USA) and K-Ras-transformed normal derived cell line, 226.4.1 [38]
were routinely grown in Dulbecco's modiﬁed Eagle's medium
containing 10% Fetal Bovine Serum (FBS), 4 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 0.25 mg/ml amphotericin
B at 37 °C in a humidiﬁed atmosphere of 5% CO2. Growth curves and
ATP levels of cells were obtained by seeding 6×104 cells in DMEM
containing either glucose 25 mM or 1 mM, 110 mg/l pyruvate, 4 mM
glutamine, and supplemented with 10% FBS. To enhance potential
alterations in respiratory chain-dependent ATP synthesis cells were
grown in DMEM glucose-free medium containing 5 mM galactose,
110 mg/l pyruvate, and 4 mM glutamine, supplemented with 10%
dialyzed fetal bovine serum. The growth ability of cell lines was
assayed by changing daily the culture medium and counting cells till
72 h.
2.2. RNA preparation and Affymetrix Analysis
To probe the global gene expression in our ﬁbroblasts, along a
time course, RNA was extracted as described previously [14] and
mouse genome 430 2.0 array Affymetrix (Affymetrix, Santa Clara,
CA) were used. The mouse genome 430 2.0 array is a high-density
oligonucleotide array comprised of over 45,101 probe sets repre-
senting over 34,000 well-substantiated mouse genes. For all the
experiments we used MAS5 pre-processing method with default
parameters. Expression analysis ﬁles originated from each sample
(chip) were then imported in GeneSpring 7.3.1 (Silicon Genetics) for
further analysis. In particular, for the normalization procedure,
probe-set values below 0.01 were placed to 0.01. Normalization
was performed by using a per-chip 50th percentile method that
normalizes each chip on its median, allowing comparison among
chips and using per-gene normalization where the measurement of
each probe was normalized to the median of the measurements of
that probe in the different chips. For the analysis of the data, a cross-
gene error model was applied. Further standard ﬁltering procedures
were applied (i.e. Flag had to be indicated as “Present” in at least one
sample of the time course; the samples with an intensity value below
50 units were excluded; the genes showing a standard deviation
between 0 and 1 in at least 85% of the samples were selected).
Moreover, transcriptional data obtained for the genes of each
mitochondrial Complex, have been analyzed through unsupervised
hierarchical clustering (as implemented in the GeneSpring platform).
The results of this process are the dendrograms (one for each
Complex), that typically unsupervised hierarchical clustering proce-
dure provides.
2.3. Mitochondrial ATP synthesis assay and cellular ATP content
The oligomycin-sensitive ATP synthase activity in permeabilized
cells was determined according to the method described by Sgarbi et
al. [39]. Essentially, ﬁbroblasts (3×106 cells/ml) were incubated for
12 min with 60 μg/ml digitonin in a Tris/Cl buffer (pH 7.4). Complex I
and Complex II driven ATP synthesis was induced by adding 10 mM
glutamate /10 mM malate (+0.6 mM malonate) or 20 mM succinate
(+4 μM rotenone) and 0.5 mM ADP (all reagents were from Sigma-
Aldrich, St. Louis, MO, USA) to the sample. After 5 min the reaction
was stopped by adding dimethylsulphoxide (80%) to the sample and
the ATP content was measured by the luciferine/luciferase chemilu-
minescent method.
2.4. Respiration measurements
Oxygen consumption rates were measured in permeabilized cells
(60 μg/ml digitonin) at 30 °C using an oxygen Clark-type electrode as
previously reported by Baracca et al. [40]. State 4 respiration rates
were determined by adding to cell samples 20 mM succinate (plus
4 μM rotenone) or 10 mM glutamate/10 mM malate (plus 1.8 mM
malonate). State 3 and uncoupled respiration rates were measured in
the presence of 0.8 mM ADP or 60 μM DNP (dinitrophenol),
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were sensitive to rotenone and malonate, respectively.2.5. Mitochondria isolation
We set a simple method allowing to obtain a high mitochondria
yield. Cells were harvested, washed once in PBS (1 mM KH2PO4,
3 mM Na2HPO4, 154 mM NaCl), and resuspended (10 mg/ml) in
10 mM Tris/Cl buffer (pH 7.4) containing 1 mM PMSF (phenyl-
methanesulfonyl ﬂuoride) and 0.5 mg/ml digitonin. After 7 min in
ice an equal volume of buffer (140 mM sucrose, 440 mM mannitol,
40 mM HEPES, 2 mM EDTA, 200 μM EGTA and 1 mM PMSF) was
added to the cells and the suspension was centrifuged at 600g for
10 min in a refrigerated centrifuge (Beckman Avanti J-25 centrifuge
equipped with a JA18.1 rotor). The supernatant was decanted and
the pellet was resuspended (10 mg/ml) in 10 mM Tris/Cl buffer (pH
7.4) containing 1 mM PMSF and 2.5 mg/ml digitonin and kept in ice
for 10 min. The permeabilized cell suspension was again diluted and
centrifuged as above. The supernatant mitochondrial fraction was
then centrifuged at 10,000g for 10 min in the refrigerated BeckmanFig. 1. Cell growth and ATP level of control and transformed cells. Cell growth (A, B, C) and AT
72 h changing the medium daily. Cells were incubated in DMEM containing 25 mM glucose
l pyruvate, 4 mM glutamine, and supplemented with either 10% FBS or dialyzed FBS when
independent experiments, each performed in triplicate (when not seen, SD was within thecentrifuge. Finally, mitochondria were washed once in buffer
(70 mM sucrose, 220 mM mannitol, 20 mM HEPES, 1 mM EDTA,
100 μM EGTA and 1 mM PMSF) and resuspended at 3–4 mg protein/
ml in 20 mM HEPES/KOH buffer containing 250 mM sucrose, 1 mM
EDTA and 100 μM EGTA, pH 7.4. The mitochondrial protein yield was
about 4%.
2.6. Complex I redox activity
NADH-CoQ oxidoreductase activity was measured in daily isolated
fresh mitochondria suspension (3.5 mg/ml) exposed to 3 cycle of
sonic radiation. The enzyme activity (30 °C) was assayed at substrates'
saturating concentration (75 μM NADH; 80 μM decylubiquinone) and
in the presence of 1.8 μM Antimycin A and 2 mM KCN to inhibit
Complex III and Complex IV, respectively. The rotenone sensitive
NADH-CoQ oxidoreductase activity (i.e. the mitochondrial redox
activity was 95% inhibited in the presence of 2 μM rotenone) was
detected following the decrease of NADH absorption at 340 – 380 nm
in a JASCO V550 UV-VIS dual wavelength spectrophotometer
equipped with a mixing apparatus. The molar absorbance coefﬁcient
used for NADH was 4.1 mM−1 cm−1.P level (D, E, F) of control (open circles) and transformed cells (ﬁlled circles) cultured for
(A, D), 1 mM glucose (B, E) or 5 mM galactose to substitute for glucose (C, F), 110 mg/
cells were cultured in galactose medium. The data are averages±SD from one of two
circle diameter).
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Citrate synthase activity and cell sample protein concentration
were determined as previously described [41].
2.8. Mitochondrial membrane potential analysis in living cells
Fluorescence micrographs of oligomycin-treated (state 4 respira-
tory condition) and untreated (state 3) adherent permeabilized-cells
were obtained using the tetramethylrhodamine methylester (TMRM)
(Molecular Probes) ﬂuorescent probe as reported in Solaini et al. [42].
Images were acquired using a ﬂuorescence inverted microscope
(Olympus IX50 equipped with a CCD camera). Multiple high-power
(20×) images were acquired with IAS2000 software (Delta Sistemi,
Italy). To quantitate ΔΨm under different metabolic conditions,
steady-state ﬂuorescence quenching measurements of permeabilized
cells incubated with rhodamine 123 (RH-123) (Molecular Probes)
were carried out as described [41,42].
Mitochondrial potential in intact cells was determined with the
probe CMX-Ros (MitoTracker Red) (Molecular Probes) using ﬂuores-
cence-activated cell sorter (FACScan, Becton-Dickinson). Brieﬂy, cells
were trypsinized by treatment with 0.25% trypsin, then wereFig. 2.Mitochondrial ATP synthesis and oxygen consumption rates measured in digitonin-pe
determined in presence of glutamate-malate (A) and succinate (B) as respiratory substrates. O
and Complex II- (E, F) dependent substrates under state 3 (C, E) and uncoupled (D, F) respir
were considered signiﬁcantly different when P≤0.05 (⁎) or P≤0.01 (⁎⁎).suspended in 1 ml of PBS+10% FCS (0.5×106 cells per analysis)
containing the dye (60 nM) and labeled for 30min at 37 °C in the dark.
The unbound dye was then removed with one wash and promptly
used for ﬂow cytometric analysis. The percentage and the mean value
of potential was calculated for each sample and corrected for auto-
ﬂuorescence obtained from samples of unlabeled cells. Data analysis
was performed with WinMDI software.
2.9. OXPHOS complexes immunodetection and supercomplex
organization
To evaluate the OXPHOS complexes content, cellular homogenates
were electrophoretically separated by SDS-PAGE and blotted on
nitrocellulose membrane. The OXPHOS complexes estimation was
based on immunodetection and quantiﬁcation of single subunit of
each protein complex. Supercomplex organization of respiratory
complexes was analyzed in isolated digitonin-treated mitochondria
by 1D blue-native PAGE followed by 2D SDS-PAGE [19]. The protein
electrophoretic pattern obtained under denaturating conditions were
then electroblotted onto nitrocellulose membrane. The four protein
complexes were detected and quantiﬁed by a chemiluminescent
technique based on the ECL™Western Blotting Detection Reagent Kitrmeabilized cells grown for 48 h in glucose enriched medium. ATP synthesis rates were
xygen consumption rates weremeasured in cells energizedwith both Complex I -(C, D)
atory conditions. The data are averages+/-SD of three independent experiments. Data
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primary monoclonal antibodies speciﬁc for single subunits of each
respiratory complex as follows: NDUFA9 (39 kDa) of Complex I, SDHA
(70 kDa) of Complex II, Rieske protein (22 kDa, apparent molecular
weight is 30 kDa) of Complex III, COX-I (57 kDa, apparent 45 kDa) of
Complex IV (MitoSciences Inc., Eugene, OR, USA) and a secondary goat
anti-mouse IgGH+L antibody labeled with horseradish peroxidase
(Molecular Probes, Eugene, OR, USA). The molecular mass scale of the
1D electrophoresis was drawn on the basis of standard proteins
(HMW calibration kit for Native electrophoresis, Amersham
Biosciences).2.10. Statistical analysis
All statistical analyses were performed with OriginPro 7.5
(OriginLab Corporation, MA, USA), using unpaired Student's t testFig. 3.Mitochondrial membrane potential of K-ras transformed ﬁbroblasts. Typical ﬂuoresce
metabolic conditions (A, C state 3 and B, D state 4 respiration) obtained from control (A, B) a
quenching initial rate measurements of rhodamine 123 (RH-123) in digitonin-permeabilize
three independent experiments. Data were considered signiﬁcantly different when P≤0.05
cells. Cells, cultured in 25 mM glucose enriched medium for 48 h, were in vivo stained with
stained population-Mean Fluorescence-. Histogram shows themean values±SD of three ind
P≤0.01 (⁎⁎).between groups. Data show mean±SD. Groups were considered
signiﬁcantly different when P≤0.05 (⁎) or P≤0.01 (⁎⁎).3. Results
3.1. Cell growth and mitochondrial function
In order to highlight a possible bioenergetics impairment of
transformed ﬁbroblasts as compared to control ones, cell prolifer-
ation was studied under different conditions of glucose availability
(25 mM, 1 mM) and in absence of glucose (substituted by 5 mM
galactose). In particular, the proliferation ability of the two cell lines
was assayed by changing daily the culture medium and counting
cells till 72 h. As shown in Fig. 1A, in 25 mM glucose, both lines
grew linearly on a semilog plot for nearly 48 h (from now on called
“exponential growth phase”), but ras-transformed cells had ance microscopy images of TMRM-loaded digitonin permeabilized cells under different
nd transformed (C, D) cells grown for 48 h in 25 mM glucose medium. (E) Fluorescence
d cells under state 3 respiratory conditions. Histogram shows the mean values±SD of
(⁎) or P≤0.01 (⁎⁎). (F) Analysis of mitochondrial potential in control and transformed
MitoTracker Red and then analyzed by FACS. Data are reported as mean ﬂuorescence of
ependent experiments. Data were considered signiﬁcantly different when P≤0.05 (⁎) or
Fig. 4. Mitochondrial Complex I redox activity in control and transformed cells. The
NADH-Ubiquinone oxidoreductase activity was measured in fresh mitochondria
isolated daily from both cell lines. The cells were cultured in 25 mM glucose medium
for 48 h before isolating mitochondria. The data are averages±SD of three independent
experiments. Data were considered signiﬁcantly different when P≤0.05 (⁎) or P≤0.01
(⁎⁎).
Fig. 5. Content of mitochondrial OXPHOS complexes in control and transformed cells.
(A) Immunodetection of single subunits of each OXPHOS complex revealed after
SDS-PAGE separation. (B) Histogram (right) shows the densitometric analysis of
OXPHOS subunits in transformed compared to control cells. Analysis of each band
was obtained with the Quantity One software (BioRad) using Actin as internal
standard.
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glucose availability (and consequently glycolysis rate) ras-trans-
formed cells grew much more slowly than control cells (Fig. 1B and
C), resulting at 72 h in a yield ratio (cell yield in 25 mM glucose/cell
yield in 5 mM galactose) of about 8, whereas the same ratio scored
nearly 3 when estimated for wild-type cells. Similar results (not
shown) were also obtained mimicking the in vivo limited nutrients
availability of tumour cells by changing the culture medium only
once (at zero time). This behavior suggested an impairment of
OXPHOS in transformed cells. Incidentally, the ATP level (nmol/mg
cell protein) was found to be lower in ras-transformed than in
control ﬁbroblasts, and this event occurred independently of culture
conditions (Fig. 1D–F). Since ATP level is set by the steady state
balance of ATP synthesis and ATP utilization rates that may both
vary in transformed cells, only measurements of ATP synthesis rates
could detect mitochondrial impairment. Therefore we investigated
functional and structural features of the oxidative phosphorylation
system. Moreover, in order to deﬁne possible mitochondrial
dysfunctions in K-ras transformed cells, and with the hope to
elucidate the K-ras activated/repressed pathways, the OXPHOS
transcriptional proﬁling has been analyzed.
3.2. Respiratory activity and oxidative phosphorylation in
digitonin-permeabilized cells
Citrate synthase activity expressed as nmol/min/mg protein was
determined and found not signiﬁcantly changed in ras-transformed
cells as compared to control cells (C cells: 202.17±16.32; T cells:
189.85±17.96); being independent on the glucose concentration of
the culture medium (data not shown). Such ﬁndings indicate that
the average mitochondrial mass per cell is not modiﬁed by
transformation. The ATP synthesis rate of permeabilized trans-
formed cells was strongly decreased (almost 50%) with respect to
controls when glutamate-malate but not succinate was the
respiratory substrate (Fig. 2A and B). This ﬁnding indicates that a
speciﬁc deﬁcit is present at the level of Complex I of the respiratory
chain, whereas the other respiratory complexes and the ATP
synthase are not signiﬁcantly affected. Likewise, the measurement
of oxygen consumption of cells grown 48 h in high glucose in State
4 (controlled state, without ADP addition) did not show signiﬁcant
changes (data not shown), while a decrease of both State 3 (under
phosphorylating conditions) and dinitrophenol-induced uncoupled
respiration was observed with glutamate-malate as substrates in
transformed cells (Fig. 2C and D). A decrease of respiratory control
ratio was exclusively a consequence of decreased State-3 respira-
tion. In agreement with data of ATP synthesis rate, under State 3
and uncoupled respiratory conditions the succinate-sustainedoxygen consumption by transformed and control cells was very
close (Fig. 2E and F).
By means of ﬂuorescence microscopy, we have also measured
the mitochondrial transmembrane potential using the TMRM probe
in permeabilized cells. In agreement with previously reported
ﬁndings [14], ras-transformed ﬁbroblasts presented different mor-
phology with respect to wild-type ﬁbroblasts (Fig. 3 compare upper
panels with lower panels). Mitochondria energized with glutamate–
malate exhibit an increased potential in ras-transformed cells as
compared to control cells under State 3 conditions only (Fig. 3A and
C). These data were conﬁrmed by measuring the membrane
potential with an independent approach that can provide quanti-
tative information on the average mitochondrial membrane poten-
tial in cell populations [42]. This method is based on the evaluation
of the ﬂuorescence quenching of rhodamine 123 (RH-123). Analysis
by RH-123 showed in transformed ﬁbroblasts grown in 25 mM
glucose, that under State 3 conditions the ﬂuorescence quenching
initial rate, which is directly related with mitochondrial ΔΨ [43], is
35% higher than in control ﬁbroblasts (Fig. 3E). MitoTracker Red
staining in intact cells further conﬁrmed this result. Indeed,
transformed cells showed higher endogenous mitochondrial mem-
brane potential than control cells (Fig. 3F). This ﬁnding is somehow
unexpected in view of the lower rate of NAD-linked respiration.
However, transformed cells maintained in glucose-enriched medium
preferentially synthesize ATP through glycolysis than through
OXPHOS, possibly determining a higher ΔΨ as compared to control
cells when it is measured in both intact cells [42] and in
permeabilized cells under State 3 respiratory conditions [41,43].
3.3. Decrease of activity of Complex I in transformed cells
Given that the biochemical results shown above (Fig. 2) suggested
a decrease of Complex I activity, we proceeded to its measure in
mitochondria isolated from cells grown for 48 h (Fig. 4). A signiﬁcant
reduction of activity occurred in the transformed cells; the decrease of
Complex I activity was in the range of the observed NAD-dependent
respiration decrease, in line with Complex I being rate-limiting for the
respiratory chain.
Since both succinate-dependent respiration and ATP synthesis in
ras-transformed cells were not affected (Fig. 2), the activity of
Complex II (that is rate limiting for succinate oxidation) as well as
those of Complexes III, IV and V were not altered at least to an extent
Fig. 6. Two-dimensional separation of mitochondrial respiratory supercomplexes from control (Top) and transformed (Bottom) cells. Supercomplexes separation was achieved by
1D Blue-Native electrophoresis followed by 2D SDS-PAGE. 2D gels were blotted onto nitrocellulose membrane and then exposed to a cocktail of monoclonal antibodies speciﬁc for
single subunits of each respiratory complex. Protein bands of molecular mass above 1000 kDa (a, monomeric Complex I) are: b, I+III+IV: supercomplex formed by complex I,
III and IV (K-ras cells only); c, I+III: supercomplex formed by complex I and III; d, I+III+IV supercomplex formed by complex I, III, and IV (normal cells only). Incidentally, in
the control cell gel, band b results from an aggregate of proteins that includes complex I, but none of the other respiratory chain complexes.
320 A. Baracca et al. / Biochimica et Biophysica Acta 1797 (2010) 314–323sufﬁcient to become the rate-limiting step. The content of mitochon-
drial complexes was investigated in cell homogenates by gel
electrophoresis under denaturing conditions followed by western
blotting and immunodetection of OXPHOS complexes subunits (Fig.
5A and B). A signiﬁcant increase of the content of Complex III,
Complex IV and ATP synthase was observed in transformed cells with
respect to wild type, while Complex II was unchanged. At variance,
transformed cells showed a reduction of approximately 50% of
Complex I content (Fig. 5B). Moreover, 2-D electrophoretic analysis
of supercomplexes organization, while conﬁrming the depletion of
Complex I in transformed cells, showed the disappearance of the
highest molecular weight supercomplex composed by complexes I, III
and IV (Fig. 6).
3.4. Transcriptional proﬁling of nuclear genes involved in oxidative
phosphorylation
In order to extend at a molecular genome-wide level the
characterization of control and K-ras transformed ﬁbroblasts, the
time-dependent transcriptional proﬁling of the two sets of mouse
ﬁbroblasts was performed. The transcriptional analysis was per-
formed between 0 h and 72 h, because in this time interval both cell
lines did not run out glucose from the medium ([13] and unpublished
observations). Incidentally, transcriptional analysis of glycolytic genes
was previously performed [13] showing enhanced transcription of
genes for several glycolytic enzymes in T cells grown in high glucose
medium.
3.4.1. Complex I
We identiﬁed and analysed the expression of 31 nuclear genes
(out of 39) encoding subunits of Complex I (Fig. 7A). Interestingly,
in control cells the level of expression of most genes encoding
subunits of Complex I increased along the time course, whereas inFig. 7. OXPHOS nuclear gene expression analysis in control and transformed cells. The gene
represents the relative mRNA levels (Signal Log Ratio) of OXPHOS nuclear genes of control
expression data, collected at different time points (0, 24, 48 and 72 h), were subjected to st
allowing to identify metabolic genes that show signiﬁcant statistical expression (P-value≤0
left of the Figure (expression) and clustered depending on the mitochondrial complex they b
The values of such ratios were graphically expressed (top right) as low-green colour-when
when the ratio was between 0.9 and 1.1.transformed cells the expression of 12 genes only were found
enhanced with time, and many genes were less expressed.
Consequently, the difference between the expression proﬁles was
remarkable particularly at later time point (72 h) when most genes
encoding subunits of Complex I were expressed at lower levels in
transformed cells. This result is more clearly shown by the T/C ratio
(Fig. 7B, compare 0–24 h versus 72 h), in which the green box
values, representing lower expression in transformed cells, notably
increased between 24 h and 72 h (16 genes were expressed at lower
level). In conclusion, the reduction of the Complex I content in K-ras
transformed cells was in agreement with the main differences
observed in the time-dependent OXPHOS transcriptional proﬁle of
the two sets of mouse ﬁbroblasts.
3.4.2. Complex II, III, IV and V
We identiﬁed and analyzed the expression of 43 genes encoding
polypeptides of the other four OXPHOS complexes. In particular we
identiﬁed 3 genes for Complex II, 9 for Complex III, 17 for Complex IV
and 15 for Complex V. The transcriptional proﬁle analysis indicated in
both cell lines a time-dependent decrease of the expression level of
about half the genes encoding proteins of both complexes III and IV
and a general expression increase of the genes encoding proteins of
complex II and V (Fig. 7A and B).
4. Discussion
The high glycolytic rate observed in several tumour cells and
tissues may depend upon mitochondrial dysfunction and/or hypoxic
environment of developing tumour, a condition that would force
cancer cells to use essentially glycolysis to generate ATP. Mitochon-
drial dysfunctions are known to be caused either by mtDNA mutation
and/or by aberrant expression of metabolic and mitochondrial
enzymes, while hypoxia is due to low vascularization that limitsexpression analysis was performed by using Affymetrix arrays. The schematic diagram
(C) and transformed (T) cells grown in 25 mM glucose containing medium. (A) Gene
andard normalization and ﬁltering procedures, as described in Materials and methods,
.05). Data are colour-coded according to the red-green colour spectrum depicted on the
elong. (B) T/N ratios are obtained from the gene expression proﬁles of the two cell lines.
the ratio was ≤0.9, high-red colour-when the ratio was ≥1.1 and equal-yellow colour-
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direct inﬂuence of activated oncogenes on the energy metabolism of
tumours [15,44,45].
Here we made use of a model of immortalized mouse ﬁbroblasts
and isogenic K-ras transformed cells to investigate the correlation of
oncogenic ras activation with metabolic alteration and mitochondrial
(dys)function. Indeed, by using cellular models of ras transformation
from different origin (human, mouse, and rat), several reports have
shown the ability of oncogenic ras to alter cellular metabolism [46] as
well as the presence of enhanced glycolysis [37]. However, our aim
was to ascertain the possible presence of a link between the Warburg
effect in our transformed cell model [13] and mitochondrial function.
Therefore, we analyzed in detail several oxidative phosphorylation
parameters and associate them with the expression of energy
metabolism genes and level of OXPHOS complexes. Taken together
our results showed a signiﬁcant dysfunction of mitochondria in
transformed cells that is due to a decrease of Complex I activity and
consequent severe reduction of both NAD-linked respiration and ATP
synthesis, which is in agreement with the notion that Complex I is
rate-limiting over the respiratory chain [19].
The Complex I impairment well correlates with the transcriptional
proﬁles of transformed cells. Indeed at 48 h, time at which the
mitochondrial functional analysis was performed, as well as at a later
time point (72 h), we observed a signiﬁcant reduction of the
expression (T/C ratio) of most genes encoding Complex I subunits.
However, the general reduction of transcription of genes encoding
proteins ofmitochondrial complexes (particularly complex I and IV) in
transformed cells was conﬁrmed only in part by the protein analysis.
The substantial decrease of Complex I and the lack of changes of
Complex II content, as detected bywestern blotting (Ndufa9 and Sdha,
respectively),were in linewith the transcriptional behaviour;whereas
the signiﬁcant increase of content of the other OXPHOS complexes,
particularly of Complex IV, was unexpected. Indeed, in transformed
cells, at 48 h, Uqcrfs1, COX I [14] and Atp5b genes were expressed at
lower, equal and lower level, respectively than in controls.
Although the correlation between array and protein expression
data is generally poor for mitochondrial proteins [47], a possible
explanation for this discrepancy might be that ras-transformed cells
have an enhanced mRNA stability. In fact OXPHOS gene expression
and mRNA stability are strictly linked to respiratory activity, as
demonstrated in mitochondria from patients exhibiting severe
respiratory defects, that showed increased steady state levels of
nuclear transcripts encoding mitochondrial OXPHOS complexes
subunits [48]. Moreover mitochondrial respiratory chain complexes,
once assembled are extremely stable, many having half lives of up to
9 days [49,50]; this effect may explain why the reduction of mRNA for
OXPHOS genes (48 h) is not matched by the protein levels observed at
the same time point.
Why then does Complex I behave in an opposite way, and the
protein levels at 48 h appear to match mRNA decrease? Such effect
could be ascribed to a secondary damage due to enhanced ROS
production in K-ras transformed cells, as it was previously reported
[13]; that is in line with the particular vulnerability of Complex I by
ROS [51,52]. Moreover, it has been shown that the rate of newly
synthesized mitochondrial protein degradation is signiﬁcantly affect-
ed by the generation of mitochondrial free radicals [53].
An alternative explanation for the decrease of Complex I is an
impaired assembly for the lack of some post-translational event or
alteration of assembly factors [54]; indeed, the assembly of Complex I
is very complex and not yet fully understood [55]. In addition, it has
become clear that Complex I is unstable and becomes disassembled in
absence of super-complex organization [56,57]. To this purpose, it is
evident from 2D-electrophoresis (Fig. 6) that the low amount of
Complex I present in transformed ﬁbroblasts is mostly isolated and
less assembled with Complex III and Complex IV in high molecular
weight (MW) supercomplexes. In particular, the highest MW super-complex (see Fig. 6, band d) detected in control cells is almost absent
in ras-transformed ﬁbroblasts. We have previously reported [58] that
enhanced ROS generation induces dissociation of the I–III super-
complex with consequent lack of efﬁcient electron channelling from
Complex I to Complex III; moreover the concomitant disruption of
Complex I assembly induced by supercomplex dissociation [56,57]
might also account for the decrease of NAD-linked respiration and ATP
synthesis. It is tempting to speculate that activation of ubiquitin-
dependent and -independent degradation systems [59] would then be
operative to eliminate the disassembled subunits. The OXPHOS
dysfunction in K-ras transformed cells might then lead to compen-
satory enhancement of glycolysis to overcome the energetic
deﬁciency.
In conclusion, the decrease of Complex I activity in ras-
transformed ﬁbroblasts appears to be sufﬁcient to explain the
impairment of mitochondrial function and the Warburg effect.
Therefore, the observation here reported that Complex I activity is
selectively reduced in K-ras cells as it is in other types of tumours [24],
might indicate an alternative possible target in order to develop
therapeutic approaches and/or cellular diagnosis for some type of
cancers.
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